कृपया अन्य खोज का प्रयास करें
Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It’s XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company’s product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
W. Bradford Smith | 66 | 2019 | Independent Director |
Gary M. Ansel | - | - | Member of Medical Advisory Board |
Martin Schillinger | - | - | Member of Medical Advisory Board |
Elazer R. Edelman | 65 | - | Member of Scientific Advisory Board |
I. Baumgartner | - | - | Member of Medical Advisory Board |
Robert S. Langer | 73 | 2006 | Member of Scientific Advisory Board |
George M. Whitesides | 83 | 2006 | Member of Scientific Advisory Board |
Renu Virmani | - | - | Member of Scientific Advisory Board |
Michael D. Dake | - | - | Member of Medical Advisory Board |
Mark Saltzman | - | - | Member of Scientific Advisory Board |
Konstantin Poukalov | 38 | 2020 | Independent Director |
Michael Seth Altman | 40 | 2018 | Independent Director |
William A. Gray | - | - | Member of Medical Advisory Board |
Robert S. Schwartz | - | - | Member of Scientific Advisory Board |
James Morley Anderson | 81 | - | Member of Scientific Advisory Board |
Mahmood K. Razavi | - | - | Member of Medical Advisory Board |
Stephen L. Hilbert | - | - | Member of Scientific Advisory Board |
Nancy L. Snyderman | 69 | 2020 | Independent Director |
James R. Tobin | 77 | 2022 | Lead Independent Director |
Edward Thomas Anderson | 70 | 2019 | Independent Director |
Maria Palasis | 58 | 2015 | CEO, President & Director |
Harlan W. Waksal | 70 | 2022 | Executive Chairman |
C. Ann Merrifield | 72 | 2019 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है